| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Patient ID | Cohort | Newly collected? | Molecular Pathology of Initial Tumor | Molecular Pathology of Recurrent Tumor | Grade of Initial Tumor | Grade of Recurrent Tumor | Progression | Age at initial diagnosis | Gender | Geographical region | TMZ Treatment Before Recurrence | Overall Survival (OS, months) | Censor of OS (0 alive/1 dead) | Surgerical Interval (months) | Hypermutation of Initial Tumor | Hypermutation of Recurrent Tumor | IDH mutation | 1p/19q co-deletion | WGS_normal | WGS_Initial | WGS_Recurrence | WES_Normal | WES_Initial | WES_Recurrence | RNAseq Initial | RNAseq Recurrence | Mutation Source | CNA Source | MYC_status_initial | MYC_status_recurrence | MYC gain shared at initial and recurrence | |
2 | PS001 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 70 | M | non-East Asian hospitals | 1 | 6.6 | 1 | 5.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
3 | PS002 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 42 | M | non-East Asian hospitals | 1 | 17.7 | 1 | 10.0 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
4 | PS003 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 67 | M | non-East Asian hospitals | 1 | 17.1 | 1 | 8.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
5 | PS004 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 50 | F | non-East Asian hospitals | 1 | 27.2 | 1 | 5.8 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
6 | PS005 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 58 | F | non-East Asian hospitals | 1 | 12.8 | 1 | 5.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
7 | PS006 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 59 | M | non-East Asian hospitals | 1 | 17.5 | 1 | 11.3 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
8 | PS007 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 69 | M | non-East Asian hospitals | 1 | 21.3 | 1 | 11.5 | No | Yes | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
9 | PS008 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 46 | F | non-East Asian hospitals | 1 | 15.3 | 1 | 10.1 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
10 | PS009 | INCB | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 67 | F | non-East Asian hospitals | 1 | 46.4 | 1 | 40.2 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
11 | PS010 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 50 | M | non-East Asian hospitals | 1 | 22.8 | 1 | 16.5 | No | Yes | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
12 | PS011 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 53 | M | non-East Asian hospitals | 1 | 18.3 | 1 | 11.6 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
13 | PS012 | INCB | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 49 | M | non-East Asian hospitals | 1 | 45.2 | 1 | 31.9 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | copy number gain (22.8 Mb) | ||
14 | PS013 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 67 | F | non-East Asian hospitals | 1 | 25.4 | 1 | 12.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
15 | PS014 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 57 | M | non-East Asian hospitals | 1 | 9.4 | 1 | 8.0 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
16 | PS015 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 47 | M | non-East Asian hospitals | 1 | 18.6 | 1 | 14.9 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
17 | PS016 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 61 | M | non-East Asian hospitals | 1 | 18.2 | 1 | 15.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
18 | PS017 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 33 | F | non-East Asian hospitals | 1 | 30.2 | 1 | 5.8 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
19 | PS018 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 52 | M | non-East Asian hospitals | 1 | 24.9 | 1 | 17.9 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
20 | PS019 | INCB | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 48 | M | non-East Asian hospitals | 1 | 18.4 | 1 | 8.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
21 | PS020 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 53 | M | non-East Asian hospitals | 1 | 40.9 | 1 | 32.8 | No | Yes | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
22 | PS021 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 45 | F | non-East Asian hospitals | 1 | 13.4 | 1 | 11.3 | No | Yes | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
23 | PS022 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 35 | F | non-East Asian hospitals | 1 | 141.9 | 1 | 10.3 | No | Yes | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
24 | PS023 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 64 | M | non-East Asian hospitals | 1 | 18.7 | 1 | 11.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
25 | PS024 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 46 | M | non-East Asian hospitals | 1 | 16.7 | 1 | 6.5 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
26 | PS025 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 67 | F | non-East Asian hospitals | 1 | 4.4 | 1 | 0.8 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
27 | PS026 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 64 | M | non-East Asian hospitals | 1 | 18.7 | 1 | 16.3 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
28 | PS027 | MD Anderson | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 62 | F | non-East Asian hospitals | 1 | 38.8 | 1 | 8.1 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | focal amp (8.9Mb) | focal amp (5.02Mb) | Shared_MYC_gain | |
29 | PS028 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 67 | M | non-East Asian hospitals | 1 | 13.0 | 1 | 5.9 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
30 | PS029 | MD Anderson | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 52 | M | non-East Asian hospitals | 1 | 17.0 | 1 | 7.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
31 | PS030 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 64 | F | non-East Asian hospitals | 1 | 48.3 | 1 | 27.1 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
32 | PS031 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 68 | M | non-East Asian hospitals | 0 | 12.4 | 1 | 5.8 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
33 | PS032 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 66 | M | non-East Asian hospitals | 1 | 13.3 | 1 | 4.0 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
34 | PS033 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 63 | M | non-East Asian hospitals | 1 | 10.6 | 1 | 7.4 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
35 | PS034 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 73 | F | non-East Asian hospitals | 0 | 7.5 | 1 | 2.2 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
36 | PS035 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 48 | M | non-East Asian hospitals | 0 | 12.0 | 1 | 1.8 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
37 | PS036 | TCGA-GBM | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 31 | M | non-East Asian hospitals | 0 | 20.1 | 1 | 9.3 | No | No | IDHmut | noncodel | YES | YES | YES | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
38 | PS037 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 50 | M | non-East Asian hospitals | 0 | 15.3 | 1 | 6.9 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
39 | PS038 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 60 | F | non-East Asian hospitals | 0 | 16.2 | 1 | 14.9 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
40 | PS039 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 59 | F | non-East Asian hospitals | 1 | 32.5 | 1 | 28.9 | No | Yes | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
41 | PS040 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 49 | F | non-East Asian hospitals | 1 | 22.2 | 1 | 13.8 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
42 | PS041 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 51 | M | non-East Asian hospitals | 1 | 4.7 | 1 | 2.7 | No | No | IDHwt | noncodel | YES | YES | YES | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
43 | PS042 | TCGA-GBM | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 36 | M | non-East Asian hospitals | 1 | 14.3 | 1 | 2.3 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
44 | PS043 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 28 | M | non-East Asian hospitals | 1 | 58.0 | 1 | 31.0 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
45 | PS044 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 39 | F | non-East Asian hospitals | 1 | 74.0 | 1 | 56.0 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | copy number gain (83.3 Mb) | copy number gain (91.8 Mb) | Shared_MYC_gain | |
46 | PS045 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 44 | M | non-East Asian hospitals | 0 | 103.0 | 1 | 40.0 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
47 | PS046 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 28 | M | non-East Asian hospitals | 0 | 45.0 | 1 | 35.0 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
48 | PS047 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 41 | F | non-East Asian hospitals | 1 | 44.0 | 1 | 25.0 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | copy number gain (64.4 Mb) | copy number gain (24.7 Mb) | Shared_MYC_gain | |
49 | PS048 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 27 | M | non-East Asian hospitals | 1 | 59.0 | 0 | 30.0 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
50 | PS049 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 49 | M | non-East Asian hospitals | 1 | 106.0 | 0 | 94.0 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
51 | PS050 | UCSF | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 27 | M | non-East Asian hospitals | 1 | 35.0 | 1 | 21.0 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | copy number gain (57.6 Mb) | ||
52 | PS051 | UCSF-University of Tokyo hospital | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 34 | M | East Asian hospitals | 1 | 109.0 | 1 | 102.0 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | copy number gain (40.2 Mb) | copy number gain (18.0 Mb) | Shared_MYC_gain_in_East_Asian | |
53 | PS052 | UCSF-University of Tokyo hospital | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 39 | M | East Asian hospitals | 0 | 42.0 | 0 | 14.0 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
54 | PS053 | Kyoto | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 31 | M | East Asian hospitals | 0 | 45.0 | 0 | 45.0 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
55 | PS054 | Kyoto | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 23 | M | East Asian hospitals | 1 | 37.8 | 0 | 37.8 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | copy number gain (98.5 Mb) | copy number gain (38.1 Mb) | Shared_MYC_gain_in_East_Asian | |
56 | PS055 | Kyoto | No | Diffuse Astrocytoma, IDH-mutant | Glioblastoma, IDH-mutant | II | IV | Progression | 48 | F | East Asian hospitals | 1 | 38.2 | 0 | 38.2 | No | Yes | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | copy number gain (24.7 Mb) | copy number gain (16.1 Mb) | Shared_MYC_gain_in_East_Asian | |
57 | PS056 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 42 | F | East Asian hospitals | 1 | 60.7 | 0 | 24.1 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
58 | PS057 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 53 | M | East Asian hospitals | 1 | 57.8 | 1 | 8.6 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
59 | PS058 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 70 | F | East Asian hospitals | 1 | 53.3 | 0 | 37.5 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
60 | PS060 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 32 | M | East Asian hospitals | 1 | 38.8 | 0 | 14.3 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
61 | PS061 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 48 | M | East Asian hospitals | 1 | 34.8 | 1 | 2.3 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
62 | PS062 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 24 | M | East Asian hospitals | 1 | 34.2 | 0 | 27.0 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
63 | PS063 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 34 | F | East Asian hospitals | 1 | 32.7 | 0 | 29.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
64 | PS064 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 56 | F | East Asian hospitals | 1 | 42.3 | 0 | 8.8 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
65 | PS065 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 38 | F | East Asian hospitals | 1 | 25.8 | 1 | 14.9 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
66 | PS066 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 51 | M | East Asian hospitals | 1 | 23.3 | 0 | 14.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
67 | PS067 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 51 | M | East Asian hospitals | 1 | 22.0 | 1 | 6.6 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
68 | PS068 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 74 | M | East Asian hospitals | 1 | 19.1 | 1 | 15.6 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
69 | PS069 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 46 | F | East Asian hospitals | 1 | 17.5 | 1 | 10.3 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | copy number gain (8.5 Mb) | ||
70 | PS070 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 72 | F | East Asian hospitals | 1 | 16.6 | 0 | 6.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
71 | PS071 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 65 | M | East Asian hospitals | 1 | 15.5 | 1 | 11.0 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
72 | PS072 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 74 | M | East Asian hospitals | 1 | 13.8 | 1 | 5.4 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | focal amp (0.05 Mb) | ||
73 | PS073 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 66 | M | East Asian hospitals | 1 | 13.3 | 1 | 12.0 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
74 | PS074 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 41 | M | East Asian hospitals | 1 | 12.0 | 1 | 6.9 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
75 | PS075 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 52 | M | East Asian hospitals | 1 | 7.3 | 1 | 5.6 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
76 | PS076 | SMC_old | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 40 | M | East Asian hospitals | 1 | 57.6 | 1 | 2.6 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
77 | PS078 | SMC_old | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 39 | M | East Asian hospitals | 1 | 81.5 | 1 | 28.6 | No | No | IDHmut | noncodel | NO | NO | NO | NO | YES | YES | YES | YES | NA | NA | NA | NA | ||
78 | PS079 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 47 | M | East Asian hospitals | 1 | 39.6 | 0 | 19.1 | No | No | IDHwt | noncodel | NO | NO | NO | NO | YES | YES | NO | NO | NA | NA | NA | NA | ||
79 | PS080 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 60 | M | East Asian hospitals | 1 | 33.0 | 1 | 20.4 | No | No | IDHwt | noncodel | NO | NO | NO | NO | YES | YES | YES | YES | NA | NA | NA | NA | ||
80 | PS081 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 58 | F | East Asian hospitals | 1 | 16.9 | 1 | 7.1 | No | No | IDHwt | noncodel | NO | NO | NO | NO | YES | YES | YES | YES | NA | NA | NA | NA | ||
81 | PS082 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 49 | M | East Asian hospitals | 1 | 10.6 | 0 | 2.6 | No | No | IDHwt | noncodel | NO | NO | NO | NO | YES | YES | YES | YES | NA | NA | NA | NA | ||
82 | PS083 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 50 | M | East Asian hospitals | 1 | 33.7 | 1 | 15.8 | No | No | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
83 | PS084 | SMC_old | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 43 | F | East Asian hospitals | 1 | 33.1 | 1 | 20.5 | No | Yes | IDHmut | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
84 | PS085 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 51 | M | East Asian hospitals | 1 | 32.2 | 1 | 12.9 | No | No | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
85 | PS087 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 37 | F | East Asian hospitals | 1 | 27.4 | 0 | 18.3 | No | No | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
86 | PS088 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 32 | F | East Asian hospitals | 1 | 25.1 | 1 | 11.6 | No | Yes | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
87 | PS089 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 41 | M | East Asian hospitals | 1 | 15.2 | 1 | 3.5 | No | No | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
88 | PS090 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 44 | M | East Asian hospitals | 1 | 12.9 | 1 | 5.2 | No | No | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
89 | PS092 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 47 | F | East Asian hospitals | 1 | 11.0 | 1 | 6.0 | No | No | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
90 | PS093 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 73 | M | East Asian hospitals | 1 | 8.3 | 0 | 7.4 | No | No | IDHwt | noncodel | NO | NO | NO | NO | NO | NO | YES | YES | NA | NA | NA | NA | ||
91 | PS094 | SMC_old | No | Glioblastoma, IDH-mutant | Glioblastoma, IDH-mutant | IV | IV | No progression | 50 | M | East Asian hospitals | 1 | 18.6 | 0 | 8.6 | No | No | IDHmut | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
92 | PS095 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 61 | F | East Asian hospitals | 1 | 19.9 | 0 | 9.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
93 | PS096 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 47 | M | East Asian hospitals | 1 | 30.0 | 0 | 2.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | YES | Wang et al | Wang et al | wildtype | wildtype | ||
94 | PS097 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 61 | F | East Asian hospitals | 1 | 24.1 | 0 | 16.7 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
95 | PS098 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 51 | M | East Asian hospitals | 0 | 20.7 | 0 | 3.1 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | NO | NO | Wang et al | Wang et al | wildtype | wildtype | ||
96 | PS099 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 57 | F | East Asian hospitals | 1 | 19.4 | 0 | 3.1 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
97 | PS100 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 45 | M | East Asian hospitals | 1 | 17.8 | 1 | 4.8 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
98 | PS101 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 63 | F | East Asian hospitals | 1 | 14.0 | 1 | 2.8 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype | ||
99 | PS102 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 69 | M | East Asian hospitals | 1 | 16.4 | 1 | 10.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | NO | YES | YES | NA | NA | NA | NA | ||
100 | PS103 | SMC_old | No | Glioblastoma, IDH-wildtype | Glioblastoma, IDH-wildtype | IV | IV | No progression | 55 | F | East Asian hospitals | 1 | 18.6 | 1 | 3.2 | No | No | IDHwt | noncodel | NO | NO | NO | YES | YES | YES | YES | YES | Wang et al | Wang et al | wildtype | wildtype |